Package 58468-7820-3

{"route": ["ORAL"], "spl_id": "cf08f2bd-2d9a-4129-b2d7-06a79983bd20", "openfda": {"nui": ["N0000175605", "N0000175076", "N0000185503", "N0000187061"], "unii": ["YO460OQ37K"], "rxcui": ["1098416", "1098418", "1114074", "1114096"], "spl_set_id": ["e5721cb8-4185-47b9-bbb3-1c587e558a03"], "pharm_class_epc": ["Kinase Inhibitor [EPC]"], "pharm_class_moa": ["Protein Kinase Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "manufacturer_name": ["Genzyme Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (58468-7820-3)  / 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC", "package_ndc": "58468-7820-3", "marketing_start_date": "20110725"}], "brand_name": "CAPRELSA", "product_id": "58468-7820_cf08f2bd-2d9a-4129-b2d7-06a79983bd20", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Kinase Inhibitor [EPC]", "Organic Cation Transporter 2 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Protein Kinase Inhibitors [MoA]"], "product_ndc": "58468-7820", "generic_name": "Vandetanib", "labeler_name": "Genzyme Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "CAPRELSA", "active_ingredients": [{"name": "VANDETANIB", "strength": "100 mg/1"}], "application_number": "NDA022405", "marketing_category": "NDA", "marketing_start_date": "20110725", "listing_expiration_date": "20271231"}